Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH

December 28, 2007 | Comments Off on Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH

Cytogenetic and Genome Research. 2007;119(1-2):46-52. Epub 2007 Dec 14. [Link] Lindholm PM, Salmenkivi K, Vauhkonen H, Nicholson AG, Anttila S, Kinnula VL, Knuutila S. Department of Pathology, Haartman Institute and…

Malignant pleural mesothelioma: surgical management in 285 patients

December 25, 2007 | Comments Off on Malignant pleural mesothelioma: surgical management in 285 patients

The Annals of Thoracic Surgery. 2008 Jan;85(1):257-64; discussion 264. [Link] Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, Pairolero PC. Division of General Thoracic Surgery, Mayo…

Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions

December 25, 2007 | Comments Off on Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions

The Annals of Thoracic Surgery . 2008 Jan;85(1):265-72; discussion 272. [Link] Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Department of Cardiothoracic…

Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery

December 25, 2007 | Comments Off on Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery

European Journal of Cardio-Thoracic Surgery. 2007 Dec 20 [Epub ahead of print] [Link] Nakas A, Martin-Ucar AE, Edwards JG, Waller DA. Department of Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester…

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

December 25, 2007 | Comments Off on Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

Annals of Oncology Online. 2007 Dec 20 [Epub ahead of print] [Link] Castagneto B, Botta M, Aitini E, Spigno F, Degiovanni D, Alabiso O, Serra M, Muzio A, Carbone R,…

Acne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report

December 22, 2007 | Comments Off on Acne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report

Journal of Cutaneous Pathology. 2008 Jan;35(1):70-3. [Epub ahead of print] [Link] Barresi V, Vitarelli E, Barresi G. Dipartimento di Patologia Umana, Policlinico Universitario G. Martino, University of Messina, Italy. Abstract…

Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas

December 22, 2007 | Comments Off on Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas

Molecular Cancer. 2007 Dec 21;6(1):81 [Epub ahead of print] [Link] Ramos-Nino ME, Blumen SR, Mossman BT. Abstract Silencing of Fra-1, a component of the dimeric transcription factor, activator protein-1 (AP-1),…

Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions

December 22, 2007 | Comments Off on Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions

Cancer Cytopathology. 2007 Dec 20 [Epub ahead of print] [Link] Hanley KZ, Facik MS, Bourne PA, Yang Q, Spaulding BO, Bonfiglio TA, Xu H. Department of Pathology and Laboratory Medicine,…

Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia

December 22, 2007 | Comments Off on Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia

International Journal of Cancer. 2007 Dec 20 [Epub ahead of print] [Link] Reid A, Heyworth J, de Klerk NH, Musk B. Occupational Respiratory Epidemiology, School of Population Health, University of…

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin

December 21, 2007 | Comments Off on Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin

Cancer Immunity. 2007 Dec 19;7:20. [Link] Hassan R, Ebel W, Routhier EL, Patel R, Kline JB, Zhang J, Chao Q, Jacob S, Turchin H, Gibbs L, Phillips MD, Mudali S,…

Categories